Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 8 - Activating Construct News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Activating Construct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Activating Construct Today - Breaking & Trending Today
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2022 -- Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company developing novel T cell engagers, today announced that management will participate...
Source: marketscreener.com
HC Wainwright Trims Harpoon Therapeutics (NASDAQ:HARP) Target Price to $18.00
Harpoon Therapeutics (NASDAQ:HARP – Get Rating) had its target price lowered by HC Wainwright from $31.00 to $18.00 in a research report released on Monday morning, The Fly reports. The brokerage currently has a buy rating on the stock. A number of other research firms also recently weighed in on HARP. SVB Leerink cut their […]
Source: etfdailynews.com
Zacks Investment Research Lowers Harpoon Therapeutics (NASDAQ:HARP) to Hold
Zacks Investment Research lowered shares of Harpoon Therapeutics (NASDAQ:HARP – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Friday, Zacks.com reports. According to Zacks, “Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers which harness the power of […]
Source: etfdailynews.com
Harpoon Therapeutics Granted Orphan Drug Designation for HPN328 for Treatment of Small Cell Lung Cancer
SOUTH SAN FRANCISCO, Calif., March 07, 2022 -- Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company developing novel T cell engagers, today announced that the U.S. Food and... | March 7, 2022
Source: marketscreener.com